Chronic lymphocytic leukemia (CLL) is a clinical and biological heterogeneous malignant disease characterized by an accumulation of monoclonal CD19+CD5+CD23+ mature small B-lymphocytes in bone marrow, blood, and lymphoid tissues [1]. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.